Abstract deadline is extended to June 8, 2018 5:00 PM EDT

Diabetes Canada and the Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference and Annual Meetings will be held in Halifax, Nova Scotia, from October 10-13, 2018. The Diabetes Canada/CSEM Program Committee invites abstract submissions for consideration.

Online Submission:  Abstracts for the 21st Diabetes Canada/CSEM Professional Conference and Annual Meetings must be submitted online via the official abstract submission site available through our website.

Abstracts can be submitted online beginning February 14, 2018. Emails or word-processing files submitted outside the abstract submission site will NOT be accepted.

  • Withdrawal Date: June 29, 2018.
  • Processing Fee:  A non-refundable processing fee of $25.00 (CDN) will be charged for each abstract submitted. Payment must be made by credit card. Major credit cards (American Express®, Visa® and MasterCard®) will be accepted for the secured online payment. The abstract will not be considered if the fee has not been paid by the submission deadline JUNE 8, 2018).

Please note, paying the abstract submission fee does NOT register you for the conference.

  1. Selection Criteria: Originality of work, adequacy of data and clarity of exposition are the determinants in the selection of abstracts. Make abstracts as informative as possible, including a brief statement of the purpose of the study or why it was done, the methods, the results observed and conclusions based on the results. Actual data should be summarized. It is inadequate to state, “The results will be discussed” or “The data will be presented.” Any graphs and tables must be simple and will only be accepted if they are of high enough quality and resolution for printing.

NOTE: Abstracts must not have been published as a manuscript or an abstract prior to the 21st Diabetes Canada/CSEM Professional Conference and Annual Meetings (October 10-13, 2018). 

  • Encore Presentations: Abstracts accepted at other national and international conferences in 2018 may be submitted to the 2018 Diabetes Canada/CSEM Professional Conference and Annual Meetings   you must:
  • Indicate the submission as an encore presentation.
  • Include the name of the meeting and date on which the paper was originally presented.
  • Please note, encore presentation submissions will be screened under the same criteria as other contributed papers.
  • Authorship Requirements: There is no limit to the number of abstracts an author may submit; however, an author may only serve as a Presenting Author on two submissions. It is the author’s responsibility to designate a new presenter for presentation conflicts that arise due to multiple submissions. If accepted, a presenter must be a co-author listed on the abstract at the time of submission.
  • The final decision with respect to selection, programming and/or publication of any abstract will be made by the Diabetes Canada/CSEM Professional Conference Program Committee.
  •  Changes to abstracts can be made before June 8, 2018. A link to your profile will be posted in your confirmation email.

If you have questions about completing the abstract form, contact Myrtella Hodge, Coordinator, Professional Conference and Events at professional.conference@diabetes.ca.

Expenses associated with the submission and presentation of the abstract are not the responsibility of the Diabetes Canada/CSEM Professional Conference and Annual Meetings.

Rejection Criteria:

  • Abstract lacks data or includes inconsistent/ambiguous   data.
  • Abstract did not conform to instructions.
  • Abstract appears disorganized.
  • Abstract received a low rating because information was dated, the importance of the topic was not made clear or discussion of study results were vague.

Completing the Forms

Character Count and Writing Standards

Character Count: Abstracts are limited to 250 words, not including spaces. The abstract title, body and tables count toward the word limit. Abstracts can have a maximum of two tables and/or images.

Note: Abstracts are published as submitted. Please proofread your work carefully to avoid errors. All abstracts must be written in English with accurate grammar and spelling. Abstracts WILL NOT be edited by Diabetes Canada staff. Typographical and grammatical errors will appear as submitted. The Diabetes Canada office will not accept any revisions or corrections to abstracts once they are accepted.


  •  The first letter of major words in the title should be     capitalized.
  •  Author(s) first name and last name should be listed in all caps. Authors with multiple abstracts should list their names the same way on all abstracts.
  •  Presenting author(s) must be indicated by an asterisk (*) after their name.
  •  Author(s) with potential conflicts of interest must be identified by a dagger (†) after their name.
  • All abstracts must be submitted in both blinded and unblinded formats. For the blinded format, identifiers such as city, province or institution name should not be included within the title or body of the abstract. This ensures that both the reviewers and the authors are concealed to allow a fair review process.
  • To submit your abstracts, there will be two containers below.  Container 1 will be used for the unblinded abstract and container 2 for the blinded abstract.
  • Screen 1: Abstracts submitted here will be used for publication. The following information will be required: Abstract Title (the first letter of major words in the title should be capitalized) and author(s) complete first, middle initial and last name(s) (names should be listed in all caps). Authors with multiple abstracts should list their names the same way on all abstracts.
  • Screen 2: Abstracts submitted here should only include the abstract title and the abstract. Author(s) names and institutions should not be included.
  • Within the online form, indicate the appropriate category under which you wish to have the abstract reviewed. The Diabetes Canada/CSEM Professional Conference Committee reserves the right to move an abstract that has been inappropriately categorized without notifying the author(s).
  • The use of standard abbreviations is required. Examples include kg, g, mg, mL, L, meq, m, mmol/L and %. Abbreviated terms should be expanded at first mention with the abbreviation in parentheses. The abbreviation can then be used throughout the rest of the abstract. Use numerals to indicate numbers, except when beginning sentences.
  • Non-proprietary (generic) names should be used the first time a drug is mentioned and typed in lowercase letters; trade names are always capitalized, for example, aspirin (Bufferin).
  • Simple tables or special symbols may be included.
  • The Diabetes Canada/CSEM Professional Conference Program Committee will consider presentation preferences. For example, an abstract marked as “Only” indicates that the authors do not want the abstract considered for any other type of presentation. If an abstract is marked as “Oral Only” and is not selected for an oral presentation, the committee will not place it in a poster session. Marking an abstract as “Oral Only” will not guarantee its selection for the program.

All author(s) must complete the http://www.icmje.org/conflicts-of-interest/  and these forms must be included with each abstract submitted.

  • The information requested for the corresponding author must be provided. The corresponding author will receive notification of abstract status. Should the corresponding author prefer, a different email address may be submitted for abstract correspondence and notification of abstract status.
  • If the research presented in the abstract has been supported, in whole or in part, by a grant from Diabetes Canada, please indicate so by checking the appropriate box. Accepted abstracts with Diabetes Canada funding will be highlighted in the conference program. Responses provided to this question will not affect the acceptance of the abstract.

Abstract Categories

Please choose one of the following abstract categories under which you would like your abstract reviewed.

Review Categories


Bone and Calcium Metabolism

Clinical Care -  Anti-diabetic Drug Therapy

Clinical Care


Clinical Care - Healthcare Delivery

Clinical Care - Insulin Therapy

Clinical Practice



Education Interventions (programming


Growth Factors

Healthcare - Delivery

Gut Hormones



Hypothalamus and Neuroendocrinology


Insulin Action/Resistance

Islet Biology

Lipid Disorders






Population Health




Quality Improvement

Reproductive Endocrinology


Thyroid Therapy



Submission Methods

Upon successful submission using the online abstract submission website, the corresponding author (and additional email address if provided) will receive an acknowledgement of receipt. Please email Myrtella Hodge at professional.conference@diabetes.ca  if you did not receive your email confirmation within 48 hours after submitting your abstract.

Abstract Status

A letter of notification of the abstract status and appropriate accompanying materials will be sent by email to the presenting author in mid-July 2018.

  • Oral Presentation: Oral presentations are 15 minutes in length. Those selected for an oral presentation will receive their presentation details (date/time) in their acceptance letter.
  • Poster Presentation: Posters must be displayed for the three days (Thursday, Friday and Saturday) in the poster hall. The Presenting Author must be available on his/her assigned Poster Session presentation day to answer questions from attendees. Those accepted for a Poster Presentation will receive their presentation details (date/time) in their acceptance letter.

Diabetes Canada/CSEM Professional Conference Abstract Travel Award (Optional Application)


The Diabetes Canada/CSEM Professional Conference Abstract Travel Award encourages outstanding research conducted in Canada by diabetes educators and scientific trainees in the field of diabetes and other endocrine disorders. Awards consist of a Travel Voucher up to a maximum of CAD $500, to be provided upon receipt of original receipts for travel, accommodation and registration expenses. Awards will be based on highest abstract rating scores.

Prospective applicants will be considered for an award if:

  • All of the eligibility requirements outlined below are met.
  • The Travel Award section of the online abstract submission form has been completed.
  • The box has been checked, indicating that the abstract should be considered for an Abstract Travel Award.


The Abstract Travel Award will be awarded for research conducted by a Canadian citizen or landed immigrant in the field of diabetes or other endocrine disorders at a Canadian institution.

The applicant must be the first author on the abstract submitted for review and must be prepared to present the work should it be accepted for presentation.

All applicants or their supervisors must be current members of the Diabetes Canada Professional Section or CSEM.

Only trainees (graduate students or postdoctoral fellows) training with a member of the Diabetes Canada Professional Section or CSEM will be eligible for review by the Diabetes Canada Professional Section or CSEM Program Committees. Supervisors must agree to supplement the trainee’s travel if the abstract wins, and must sign the application agreeing to these commitments. All Professional Section members are eligible for an Abstract Travel Award.

Abstract Trainee Awards:

Every year, the CSEM offer a number of awards to honor its contributions of their members to research, leadership, teaching and service to the Canadian endocrine community. Accepted abstracts to the 2018 Diabetes Canada/CSEM Professional Conference and Annual Meetings are eligible for the following awards:

Dr. John Dupré Award:

Two $500 honoraria and certificates will be awarded to the trainees who present the two highest ranked oral or poster clinical research projects at the CSEM Annual Professional Conference.

Dr. Charles Hollenberg Award:

Two $500 honoraria and certificates will be awarded to the trainees who present the two highest ranked oral or poster basic science/translational research projects at the CSEM Annual Professional Conference.


  1. Accepted abstract to the 2018 Diabetes Canada/CSEM Professional Conference and Annual Meetings.
  2. Presenting author is identified as a trainee and credentials provided from the abstract submission platform.
  3. Presenting author agrees to be considered for the abovementioned awards by clicking a checkbox on the abstract submission platform.
  4. Be a CSEM Trainee Member (Free – Join at https://csem.wildapricot.org).

All abstract submissions must conform to the abstract guidelines.

Keep diabetes research moving forward

Your donation will ensure research never stops – help End Diabetes Now.